PAMED News

The Pennsylvania Medical Society (PAMED) is proud to announce Ada-Nkem Emuwa, MD, MPH as the recipient of its 2025 Community Voluntary Service Award, honoring her unwavering dedication to advancing health care, promoting diversity, and supporting underserved communities through advocacy and service.

The Patient Safety Authority (Authority) announces a meeting of the Authority's Board to be held virtually by means of the Authority's webinar platform Zoom on Tuesday, September 16, 2025, at 1 p.m. and is open to the general public.

A new legislative effort is underway to ensure Pennsylvanians continue to have access to essential vaccines—regardless of changes in federal guidelines.

The Pennsylvania Medical Society (PAMED) wholeheartedly supports Governor Josh Shapiro’s comments made during his recent budget address, which highlighted the growing issue of private equity's negative impact on healthcare and patient care in the Commonwealth.

A late summer increase in COVID-19 activity in Pennsylvania is occurring. Based on national respiratory virus surveillance, test positivity for COVID-19 in PA has increased sharply in the past three weeks.

On Wednesday, September 24, 2025, the Pennsylvania Boards of Medicine and Osteopathic Medicine (collectively, “Boards”) voted in support of the issuance of guidance on immunizations by the Pennsylvania Department of Health (DOH).

The Pennsylvania Medical Society created the following principles on Maintenance of Certification during the 2014 House of Delegates:

On July 28, 2025, the Federal Trade Commission (FTC) announced it is inviting public comment to “better understand how consumers may have been exposed to false or unsupported claims about ‘gender-affirming care’ (GAC), especially as it relates to minors, and to gauge the harms consumers may be experiencing.” The 60-day comment period runs through September 26, 2025.

The Pennsylvania Department of Drug and Alcohol Programs (DDAP) and Penn State’s Douglas W. Pollock Center for Addiction Outreach and Research recently held a webinar titled Rewriting the Story: Talking About Substance Use Disorder With Care.

The Pennsylvania Department of Health (DOH) was notified by the Centers for Disease Control and Prevention (CDC) and Pfizer Pharmaceuticals that there is a nationwide voluntary recall and subsequent near-term stockout of Benzathine Penicillin G (Bicillin L-A®)